129 related articles for article (PubMed ID: 22198723)
1. The role of dual-phase Tc-99m MIBI in the evaluation of potentially operable lesions detected by bone scanning in fibrous dysplasia: a long-term prospective follow-up study.
Ones T; Erol B; Aras M; Dede F; Erdil TY; Inanir S; Turoglu HT
Nucl Med Commun; 2012 Mar; 33(3):288-96. PubMed ID: 22198723
[TBL] [Abstract][Full Text] [Related]
2. Fibrous dysplasia associated with primary hyperparathyroidism in the absence of the McCune-Albright syndrome: Tc-99m MIBI and Tc-99m MDP findings.
Kim SJ; Seok JW; Kim IJ; Kim YK; Jung DS; Kim DS
Clin Nucl Med; 2003 May; 28(5):416-8. PubMed ID: 12702945
[No Abstract] [Full Text] [Related]
3. Dual-phase (99m)Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables.
Qiu ZL; Wu B; Shen CT; Zhu RS; Luo QY
Ann Nucl Med; 2014 Oct; 28(8):725-35. PubMed ID: 25120244
[TBL] [Abstract][Full Text] [Related]
4. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
5. The role of radionuclide bone scintigraphy in fibrous dysplasia of bone.
Zhibin Y; Quanyong L; Libo C; Jun Z; Hankui L; Jifang Z; Ruisen Z
Clin Nucl Med; 2004 Mar; 29(3):177-80. PubMed ID: 15162988
[TBL] [Abstract][Full Text] [Related]
6. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
[TBL] [Abstract][Full Text] [Related]
7. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-MIBI imaging of cutaneous AIDS-associated Kaposi's sarcoma.
Peer FI; Pui MH; Mosam A; Rae WI
Int J Dermatol; 2007 Feb; 46(2):166-71. PubMed ID: 17269969
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
[TBL] [Abstract][Full Text] [Related]
10. The value of
Zhang L; He Q; Li W; Zhang R
BMC Med Imaging; 2017 Jul; 17(1):46. PubMed ID: 28738834
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-MIBI scintigraphy in musculoskeletal tumors.
Pinkas L; Robinson D; Halperin N; Mindlin L; Cohenpour M; Baumer M; Home T
J Nucl Med; 2001 Jan; 42(1):33-7. PubMed ID: 11197977
[TBL] [Abstract][Full Text] [Related]
12. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of (99m)Tc-IgG scintigraphy in the diabetic foot and comparison with (99m)Tc-MDP scintigraphy.
Asli IN; Javadi H; Seddigh H; Mogharrabi M; Hooman A; Ansari M; Jalallat S; Assadi M
J Nucl Med Technol; 2011 Sep; 39(3):226-30. PubMed ID: 21795373
[TBL] [Abstract][Full Text] [Related]
15. Preoperative detection of parathyroid adenomas with Tc-99m MIBI and Tc-99m pertechnetate scintigraphy: histopathological and biochemical correlation with Tc-99m MIBI uptake.
Akin M; Atasever T; Kurukahvecioglu O; Dogan M; Gokaslan D; Poyraz A; Koksal H; Taneri F
Bratisl Lek Listy; 2009; 110(3):166-9. PubMed ID: 19507637
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary application of 99Tc(m)-MIBI scintigraphy for judgment of bone malignant and benign lesions].
Jia ZY; Deng HF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):689-92. PubMed ID: 17718443
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Tc-99m HIG and three-phase Tc-99m MDP bone scintigraphy for evaluating the efficacy of Yttrium-90 silicate radionuclide synovectomy.
Arzu Gencoglu E; Aras G; Kucuk O; Atay G; Tutak I; Ataman S; Soylu A; Ibis E
Clin Nucl Med; 2003 Apr; 28(4):277-85. PubMed ID: 12642704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
